Published in Drug Week, December 2nd, 2005
"In an open-label trial," researchers in the United States "have previously demonstrated that paroxetine reduces hot flashes."
V. Stearns and colleagues "initiated a stratified, randomized, double-blind, cross-over, placebo-controlled trial to investigate the efficacy of paroxetine 10 mg and 20 mg compared to placebo in reducing hot flash frequency and composite score. A secondary objective was to evaluate quality of life (QOL) parameters."
They explained, "Women who suffered at least two hot flashes a day for 1 month or longer were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week